SHERWIN STEPHEN A sold NBIX
May 29, 2024 · Form 4 insider transaction
SHERWIN STEPHEN A sold 25,000 shares of Neurocrine Biosciences, Inc. at $133.46 per share, a transaction worth $3.34M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2024.; Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $132.22 to $136.37. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.